Phathom Pharmaceuticals Inc.
PHAT | NASDAQ
$7.78
+$0.33 (+4.43%)
Sep 22, 2026, 2:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.48 | -1.53 | -2.32 | -1.97 | -4.92 | -8.28 |
PEG Ratio | 0.13 | -0.04 | 0.07 | -0.05 | 19.72 | 0.16 |
PS Ratio | 6.91 | 9.28 | 686.61 | n/a | n/a | n/a |
PB Ratio | -2.76 | -2.02 | -6.44 | -5.87 | 10.09 | 5.68 |
P/FCF Ratio | -7.25 | -1.92 | -3.36 | -2.97 | -4.89 | -15.61 |
P/OCF Ratio | -7.25 | -1.92 | -3.40 | -3 | -4.90 | -15.84 |
OCF/S Ratio | -95.24 | -482.82 | -20.17K | n/a | n/a | n/a |
Debt / Equity Ratio | -0.48 | -2.19 | -1.91 | -1.30 | 1.27 | 0.25 |
Quick Ratio | 1.69 | 4.16 | 10.22 | 6.12 | 9.86 | 5.25 |
Current Ratio | 1.73 | 4.20 | 10.25 | 6.12 | 9.86 | 5.25 |
Asset Turnover | 0.68 | 0.15 | 0 | n/a | n/a | n/a |
Interest Coverage | -2.35 | -3.85 | -3.99 | -6.32 | -19.90 | -27.43 |
Return on Equity | 50.49% | 131.84% | 277.07% | 264.29% | -199.41% | -66.44% |
Return on Assets | -85.37% | -88.37% | -48.71% | -119.97% | -75.96% | -43.74% |
Return on Invested Capital | -125.23% | -88.69% | -44.52% | -123.81% | -79% | -50.79% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 87.09% | 85.57% | 75.51% | n/a | n/a | n/a |
Net Profit Margin | -126.35% | -605.09% | -29.56K% | n/a | n/a | n/a |
Pretax Profit Margin | -126.35% | -605.09% | -29.56K% | n/a | n/a | n/a |
Operating Profit Margin | -91.36% | -502.18% | -24.53K% | n/a | n/a | n/a |
FCF Margin | -95.24% | -483.07% | -20.41K% | n/a | n/a | n/a |
EBITDA Margin | -87.09% | -473.33% | -23.32K% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PHAT